Rang	Name	Position
1	Dr. John F. Milligan Ph.D.	Executive Chairman
2	Dr. David H. Kirn M.D.	Co-Founder, President, CEO & Director
3	Mr. Kristian Humer M.B.A.	CFO and Principal Financial & Accounting Officer
4	Dr. Fariborz Kamal Ph.D.	Chief Technical Advisor
5	Ms. Theresa Janke	Co-Founder & Chief of Staff
6	Julian Pei	Head of Investor Relations & Corporate Finance
7	Dr. Katy Barglow Ph.D.	Chief Technical Officer
8	Dr. Scott P. Bizily J.D., Ph.D.	Chief Legal Officer & Corporate Secretary
9	Dr. An Song Ph.D.	Chief Translational Medicine Advisor
10	Dr. Noriyuki Kasahara M.D., Ph.D.	Chief Scientific Advisor

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	HHG PLC	9,50%	69,11 Mio. USD
2	RA Capital Management, LLC	9,14%	66,51 Mio. USD
3	The Goldman Sachs Group Inc	7,61%	55,39 Mio. USD
4	BlackRock Inc	7,50%	54,59 Mio. USD
5	Novo A/S	6,61%	48,08 Mio. USD
6	Bvf Inc	5,21%	37,92 Mio. USD
7	State Street Corp	4,90%	35,66 Mio. USD
8	Adage Capital Partners Gp LLC	4,07%	29,62 Mio. USD
9	Trails Edge Capital Partners, LP	4,03%	29,34 Mio. USD
10	Vanguard Capital Management, LLC	3,97%	28,92 Mio. USD
11	Armistice Capital, LLC	3,62%	26,34 Mio. USD
12	Geode Capital Management, LLC	1,93%	14,03 Mio. USD
13	Bank of America Corp	1,76%	12,83 Mio. USD
14	Parkman Healthcare Partners LLC	1,72%	12,49 Mio. USD
15	Dimensional Fund Advisors, Inc.	1,32%	9,63 Mio. USD
16	Deutsche Bank AG	1,28%	9,33 Mio. USD
17	Citadel Advisors Llc	1,24%	9,06 Mio. USD
18	Renaissance Technologies Corp	1,05%	7,62 Mio. USD
19	Diadema Partners LP	1,03%	7,52 Mio. USD
20	Nuveen, LLC	1,02%	7,40 Mio. USD